Editorial: Dopaminergic Alterations in Schizophrenia
Front Neurosci
.
2021 Mar 11:15:663245.
doi: 10.3389/fnins.2021.663245.
eCollection 2021.
Authors
Mark D Tricklebank
1
,
Carol Tamminga
2
,
Andrew Grottick
3
,
Pierre M Llorca
4
,
Silvia Gatti McArthur
5
,
Jean-Claude Martel
6
Affiliations
1
King's College London, London, United Kingdom.
2
UT South Western Medical Center, Department of Psychiatry, Dallas, TX, United States.
3
Beacon Discovery, San Diego, CA, United States.
4
Department of Psychiatry, CHU, Clermont-Ferrand, France.
5
McArthur and Associates GmbH, Basel, Switzerland.
6
Université du Québec en Abitibi Témiscamingue, Rouyn-Noranda, QC, Canada.
PMID:
33776646
PMCID:
PMC7991723
DOI:
10.3389/fnins.2021.663245
No abstract available
Keywords:
PDE10 inhibition; antipsychotics; dopamine; neurocircuits; schizophrenia.
Publication types
Editorial